China-Made Devices Could Offer Steep Competition By 2010, Exec Says
This article was originally published in PharmAsia News
Executive Summary
Within two years Chinese brands of medical devices "will be very noticeable in the world market," says Julio A. Reategui, who directs Asia-Pacific compliance and regulatory affairs for medical imaging firm Medrad
You may also be interested in...
Mindray Doubles Patient Monitor Biz, Builds U.S. Presence Through Datascope
Shenzhen-based Mindray Medical will supply components for Datascope's patient monitoring unit after acquiring the subsidiary for $202 million in a deal announced March 11
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).